177 related articles for article (PubMed ID: 19605562)
1. The insulin-like growth factor (IGF)-I E-peptides modulate cell entry of the mature IGF-I protein.
Pfeffer LA; Brisson BK; Lei H; Barton ER
Mol Biol Cell; 2009 Sep; 20(17):3810-7. PubMed ID: 19605562
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies to the carboxy-terminal Ea sequence of pro-insulin-like growth factor-IA (proIGF-IA) recognize proIGF-IA secreted by IM9 B-lymphocytes.
Wilson HE; Westwood M; White A; Clayton PE
Growth Horm IGF Res; 2001 Feb; 11(1):10-7. PubMed ID: 11437469
[TBL] [Abstract][Full Text] [Related]
3. Human IGF-I propeptide A promotes articular chondrocyte biosynthesis and employs glycosylation-dependent heparin binding.
Shi S; Kelly BJ; Wang C; Klingler K; Chan A; Eckert GJ; Trippel SB
Biochim Biophys Acta Gen Subj; 2018 Mar; 1862(3):567-575. PubMed ID: 29174671
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor-I E-peptide activity is dependent on the IGF-I receptor.
Brisson BK; Barton ER
PLoS One; 2012; 7(9):e45588. PubMed ID: 23029120
[TBL] [Abstract][Full Text] [Related]
5. Mutational analysis of the insulin-like growth factor I prohormone processing site.
Duguay SJ; Lai-Zhang J; Steiner DF
J Biol Chem; 1995 Jul; 270(29):17566-74. PubMed ID: 7615562
[TBL] [Abstract][Full Text] [Related]
6. Viral expression of insulin-like growth factor I E-peptides increases skeletal muscle mass but at the expense of strength.
Brisson BK; Spinazzola J; Park S; Barton ER
Am J Physiol Endocrinol Metab; 2014 Apr; 306(8):E965-74. PubMed ID: 24569593
[TBL] [Abstract][Full Text] [Related]
7. Nucleotide sequence and tissue distribution of three insulin-like growth factor I prohormones in salmon.
Duguay SJ; Park LK; Samadpour M; Dickhoff WW
Mol Endocrinol; 1992 Aug; 6(8):1202-10. PubMed ID: 1406698
[TBL] [Abstract][Full Text] [Related]
8. IGF expression in HPV-related and HPV-unrelated human cancer cells.
Durzyńska J; Barton E
Oncol Rep; 2014 Sep; 32(3):893-900. PubMed ID: 25018100
[TBL] [Abstract][Full Text] [Related]
9. Identification of the IGF-1 processing product human Ec/rodent Eb peptide in various tissues: Evidence for its differential regulation after exercise-induced muscle damage in humans.
Vassilakos G; Philippou A; Koutsilieris M
Growth Horm IGF Res; 2017 Feb; 32():22-28. PubMed ID: 27836414
[TBL] [Abstract][Full Text] [Related]
10. The intrinsically disordered E-domains regulate the IGF-1 prohormones stability, subcellular localisation and secretion.
Annibalini G; Contarelli S; De Santi M; Saltarelli R; Di Patria L; Guescini M; Villarini A; Brandi G; Stocchi V; Barbieri E
Sci Rep; 2018 Jun; 8(1):8919. PubMed ID: 29891966
[TBL] [Abstract][Full Text] [Related]
11. The insulin-like growth factor (IGF)-I E-peptides are required for isoform-specific gene expression and muscle hypertrophy after local IGF-I production.
Barton ER; DeMeo J; Lei H
J Appl Physiol (1985); 2010 May; 108(5):1069-76. PubMed ID: 20133429
[TBL] [Abstract][Full Text] [Related]
12. The complexity of the IGF1 gene splicing, posttranslational modification and bioactivity.
Philippou A; Maridaki M; Pneumaticos S; Koutsilieris M
Mol Med; 2014 May; 20(1):202-14. PubMed ID: 24637928
[TBL] [Abstract][Full Text] [Related]
13. Effect of fasting on insulin-like growth factor (IGF)-IA and IGF-IB messenger ribonucleic acids and prehormones in rat liver.
Zhang J; Whitehead RE; Underwood LE
Endocrinology; 1997 Aug; 138(8):3112-8. PubMed ID: 9231757
[TBL] [Abstract][Full Text] [Related]
14. Viral expression of insulin-like growth factor-I isoforms promotes different responses in skeletal muscle.
Barton ER
J Appl Physiol (1985); 2006 Jun; 100(6):1778-84. PubMed ID: 16439513
[TBL] [Abstract][Full Text] [Related]
15. The characterization of prepro-insulin-like growth factor-1 Ea-2 expression and insulin-like growth factor-1 genes (devoid 81 bp) in the zebrafish (Danio rerio).
Chen MH; Lin G; Gong H; Weng C; Chang C; Wu J
Gene; 2001 May; 268(1-2):67-75. PubMed ID: 11368902
[TBL] [Abstract][Full Text] [Related]
16. The pro-forms of insulin-like growth factor I (IGF-I) are predominant in skeletal muscle and alter IGF-I receptor activation.
Durzyńska J; Philippou A; Brisson BK; Nguyen-McCarty M; Barton ER
Endocrinology; 2013 Mar; 154(3):1215-24. PubMed ID: 23407451
[TBL] [Abstract][Full Text] [Related]
17. Differential effect of proIGF-II and IGF-II on resveratrol induced cell death by regulating survivin cellular localization and mitochondrial depolarization in breast cancer cells.
Singh SK; Moretta D; Almaguel F; Wall NR; De León M; De León D
Growth Factors; 2007 Dec; 25(6):363-72. PubMed ID: 18365867
[TBL] [Abstract][Full Text] [Related]
18. The E-domain peptide of rat pro-insulin-like growth factor II (proIGF-II): properties of the peptide in serum and production by rat cell lines.
Hylka VW; Straus DS
Biochim Biophys Acta; 1990 Jan; 1051(1):6-13. PubMed ID: 2297541
[TBL] [Abstract][Full Text] [Related]
19. New insulin-like growth factor (IGF)-precursor sequences from mammalian genomes: the molecular evolution of IGFs and associated peptides in primates.
Wallis M
Growth Horm IGF Res; 2009 Feb; 19(1):12-23. PubMed ID: 18571449
[TBL] [Abstract][Full Text] [Related]
20. Alternative splicing produces messenger RNAs encoding insulin-like growth factor-I prohormones that are differentially glycosylated in vitro.
Bach MA; Roberts CT; Smith EP; LeRoith D
Mol Endocrinol; 1990 Jun; 4(6):899-904. PubMed ID: 2233747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
